Related Experiment Videos
Reduction of endotoxin-induced inflammation of the middle ear by polymyxin B
1Department of Otolaryngology--Head and Neck Surgery, Eastern Virginia Medical School, Norfolk 23507, USA.
Abstract:
Endotoxin (ET) is an aggregate of lipo-oligosaccharide and protein found in the cell wall of gram-negative bacteria. A potent mediator of inflammatory responses, ET has been detected in middle ear effusions from patients with otitis media with effusion and chronic suppurative otitis media and used to induce inflammation of the middle ear mucosa and disruption of mucociliary transport in experimental animals. Polymyxin B, a polypeptide antibiotic, has been shown to bond to and inactivate the ET molecule. This study investigated the efficacy of polymyxin B as a modulator of the inflammatory response to endotoxin in the middle ear. In a guinea pig model, cellular infiltrate, effusion volume, and mucosal edema in response to ET were reduced in the presence of polymyxin B. These results suggest a potential role for the use of polymyxin B in the management of middle ear effusion.
Insights
Polymyxin B effectively reduced inflammation and effusion in the middle ear caused by endotoxin (ET) in a guinea pig model. This suggests Polymyxin B may help manage middle ear effusion associated with bacterial infections.
Area of Science:
- Otolaryngology
- Microbiology
- Pharmacology
Background:
- Endotoxin (ET), from gram-negative bacteria, triggers potent inflammatory responses.
- ET is found in middle ear effusions and causes inflammation and impaired mucociliary transport.
- Polymyxin B is known to bind and inactivate ET.
Purpose of the Study:
- To investigate the efficacy of Polymyxin B in modulating endotoxin-induced middle ear inflammation.
- To assess the therapeutic potential of Polymyxin B for middle ear effusion management.
Main Methods:
- A guinea pig model was used to study middle ear inflammation.
- Endotoxin was administered to induce inflammation.
- The effect of Polymyxin B on inflammatory markers was evaluated.
Main Results:
- Polymyxin B significantly reduced cellular infiltrate in the middle ear.
- Effusion volume and mucosal edema were decreased in the presence of Polymyxin B.
- These findings demonstrate ET-induced inflammation modulation.
Conclusions:
- Polymyxin B shows efficacy in mitigating endotoxin-mediated middle ear inflammation.
- The study suggests a potential therapeutic role for Polymyxin B in treating middle ear effusion.
- Further research may support Polymyxin B in managing otitis media complications.